Xcout Intel
SeqOne Genomics competitors & alternatives
The 12 closest competitors and alternatives to SeqOne Genomics among biotechnology companies — ranked by similarity to what SeqOne Genomics actually does, not by market-cap band.
Subscribe to see SeqOne Genomics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About SeqOne Genomics
SeqOne Genomics is a certified medical device and technology company providing a smart genomics platform that leverages artificial intelligence to support genomic data analysis.
SeqOne Genomics at a glance
SeqOne Genomics is a biotechnology company headquartered in France. Its most recent funding round, Growth Round, raised $20.8M in May 2025. Xcout tracks 3 named people at SeqOne Genomics, including Martin Dubuc (Chief Executive Officer).
SeqOne Genomics leadership
- Martin DubucChief Executive Officer
- Nicolas PhilippePresident & CPSO
- Dr. Jonathan SheldonBoard of Directors
SeqOne Genomics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth Round | $20.8M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 SeqOne Genomics competitors
Ranked by semantic similarity — how close each company is to SeqOne Genomics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Biotasmart is a health-tech startup headquartered in Valencia, Spain, founded in 2024 to provide at-home gut microbiota testing using metagenomic sequencing and artificial intelligence.
Healthtech
M42 is a global tech-enabled healthcare company headquartered in Abu Dhabi. It utilizes innovative clinical solutions, genomics, and artificial intelligence to deliver precise, patient-centric medical care.
Similar biotechnology company
gMendel is a medical technology company founded in 2020 that develops an AI-powered, cloud-based platform combining genomics with artificial intelligence. The company provides decision support software designed to enable faster, more accurate, and scalable diagnosis of genetic disorders.
Biotech
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Similar biotechnology company
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Similar biotechnology company
WittGen Inc. provides a virtual cell-to-patient profiling technology powered by single-cell generative AI for clinical leaders and biopharmaceutical researchers. The company's platform transforms archived bulk RNA samples and pathological image data into regulator-ready patient stratification insights and cellular-level biomarkers to de-risk clinical trials and accelerate oncology drug development.
Biotech
Inflection Medicine provides a genomic care platform that integrates genomic data into clinical care for critically ill newborns, children, and patients across various specialties. The platform manages sequencing processes, synthesizes genetic and clinical data, provides evidence-based guidance, and creates care plans to help clinicians detect conditions early and coordinate treatment.
Diagnostics
DELFI Diagnostics is a cancer detection company that utilizes artificial intelligence and whole genome fragmentation analysis to develop blood-based cancer screening tests, such as for lung cancer.
Healthcare & Biotechnology
Genome Medical provides telehealth-enabled genetic services, offering expert genetic counseling, genetic test ordering, and clinical trial matching for patients and families. The company also partners with healthcare providers, health systems, and life sciences organizations to expand access to genetics care and improve rare disease diagnosis and management.
Biotech
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Similar biotechnology company
PhiTech is a TechBio biotechnology company headquartered in Gebze, Kocaeli, Turkey. The firm leads a global shift from DNA-only diagnostics to AI-powered multi-omics, establishing new standards for precision medicine. Utilizing advanced bioinformatics and decision analysis, the company develops cutting-edge diagnostic tools.
Similar biotechnology company
Identifai Genetics is a clinical-stage biotechnology and health tech company developing advanced prenatal screening tests using AI, machine learning, and whole genome analysis. It is headquartered in Rosh Haayin, Israel.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of SeqOne Genomics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for SeqOne Genomicsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →